Stock Spotlight Archives - Page 130 of 383

ThursdayFeb 03, 2022 3:36 pm

QualityStocksNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Miboko Launch Leveraging ‘Most Reliable Gateway Toward Wider Adoption of Preventative Health Maintenance Practices’

Nemaura Medical (NASDAQ: NMRD) recently announced it would launch Miboko, its new metabolic health program, for employers and insurers. “The Miboko application, a service offering that has been in development over the past 18 months, uses a non-invasive glucose sensor to measure and monitor users’ blood sugar levels, which are based on glucose tolerance or insulin resistance. The device is linked to an AI mobile application, which seeks to provide users with personalized information by tracking their metabolism. Users will be able to find out how well their body responds to sugar through their metabolic health score. Nemaura Medical believes…

ThursdayFeb 03, 2022 3:28 pm

QualityStocksNewsBreaks – Nowigence Inc. Bringing Critical Support in Growing Demand for PMK Solutions

Nowigence is positioned to provide critical support as the idea of personal knowledge management (“PKM”) systems is gaining traction. The company has created Pluaris(TM), a cloud-based app that automates reading and analysis of textual data and enables users to learn more in less time while uncovering hidden insights and staying on top of important information. A recent Search Engine Journal publication explains personal knowledge management as the concept “of creating a process or system for collecting and storing information for future use,” further clarifying that PKM “involves creating systems, adding context, and making information easy to surface,” (https://ibn.fm/4239C). “That’s just…

WednesdayFeb 02, 2022 3:04 pm

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Establishes Enviable Position in Legal Cannabis Market

Sugarmade (OTC: SGMD), an emerging leader in the licensed cannabis sector, is positioned in the growing legal cannabis market, which is expected to see an estimated 16.6% growth in the coming years. “At the beginning of 2021, Sugarmade CEO Jimmy Chan called 2020 a ‘landmark year’ for the company, telling shareholders that in 2021 SGMD would ‘continue to verticalize our model, creating a full farm-to-door structure that expects to produce high-quality branded cannabis products positioned in a vertical in-house supply chain. We expect that this will provide Sugarmade with optimal margins,’” a recent article reads. “The strategy for 2021 appears…

WednesdayFeb 02, 2022 2:56 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Blazing Trail in Defining Value of Rare Cannabinoids in Pharmaceutical Space

InMed Pharmaceuticals (NASDAQ: INM) is a trailblazer, a pioneer defining the value of rare cannabinoids in the pharmaceutical sector and just how integral they are in pushing the industry forward. The global cannabis market is experiencing tremendous growth, particularly considering there are over 100 known cannabinoids, including rare ones that are quickly taking over and will soon dominate the market. The potency of rare cannabinoids has given them powerful health benefits, hence their demand within the cosmetics, food and beverage, health and wellness, and pharmaceutical sectors. “InMed’s most advanced compound, INM-755, has already proven helpful in treating epidermolysis bullosa, a…

WednesdayFeb 02, 2022 2:44 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Laying Robust Foundation for Potentially Pivotal Global Trial

CNS Pharmaceuticals (NASDAQ: CNSP) recently received approval from swissethics, the umbrella organization of the cantonal Ethics Committees in Switzerland. The first from a European Ethics Committee, the approval marks a significant milestone for the company as it journeys toward its potentially pivotal study of Berubicin, an anthracycline, for the treatment of Glioblastoma Multiforme (“GBM”). The approval also partly fulfills CNS’s goal of seeing Berubicin approved for the potential treatment of GBM globally. GBM is one of the most aggressive, deadly and treatment-resistant cancers that form in the brain. “So far, the company has selected tens of clinical sites across the…

WednesdayFeb 02, 2022 2:35 pm

QualityStocksNewsBreaks – DigiMax Global Inc.’s (CSE: DIGI) (OTC: DBKSF) CryptoHawk Providing Bird’s-Eye View in Investing, Analysis in Crypto Price Trends

DigiMax Global’s (CSE: DIGI) (OTC: DBKSF) CryptoHawk is one of the world’s most powerful and complete crypto price prediction indicator tools available. CryptoHawk leverages deep learning algorithms to provide a bird’s-eye view of crypto investing, resulting in more efficient predictions. “As cryptocurrencies grow in popularity, new investors entering the space will soon find out that crypto price forecasting is extremely challenging due to the market’s price volatility and dynamism… CryptoHawk attempts to reduce some of these price forecasting challenges and is specifically designed to analyze crypto price trends and alert traders about key components that indicate the time may be right…

TuesdayFeb 01, 2022 2:01 pm

QualityStocksNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Positioning to Disrupt Global Hearing Device Market

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, is focused on its goal to provide affordable solutions to the tens of millions of Americans suffering from hearing loss today. “Through its dedicated online portal, www.iHearDirect.com, InnerScope has looked to provide consumers with affordable, Bluetooth app-controlled, self-adjusting hearing technology in a prompt and affordable manner. The company’s HearIQ App for iPhone and Android has been designed to include a free self-checking hearing test, providing billions of people worldwide with the means to detect and self-diagnose early-onset hearing loss. Meanwhile, the company’s proprietary…

TuesdayFeb 01, 2022 1:46 pm

QualityStocksNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Leadership Position Recognized in Food and Beverage, Cannabis Products Categories

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, recently announced it had been named as one of the 101 Top Food and Beverage Startups and Companies in Canada by Best Startup Canada. In addition, BevCanna was also recognized as one of the Top 101 Cannabis Startups and Companies in Canada, among innovators and growth companies within the Canadian cannabis industry. A recent article quotes BevCanna CEO Marcello Leone as saying, “This recognition of our leadership position within both the food and beverage and the cannabis products categories validates our strategy…

MondayJan 31, 2022 3:31 pm

QualityStocksNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) Bringing Safer, More Effective Nicotine Dependence Treatment to Market

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, is in an excellent position to tap into the opportunities offered by the smoking cessation market. In early 2021, one of the leading smoking cessation tools prescribed by physicians, Chantix, was pulled off the market for its cancer risk, leaving a large hole in a fast-growing sector rife with opportunity. “Mydecine has partnered with Dr. Matthew Johnson and Johns Hopkins University (‘JHU’) to advance the company’s lead drug candidate MYCO-001 as a smoking cessation treatment… In 2022, Johnson…

FridayJan 28, 2022 1:19 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Projects Largest Quarter Ever in Continued Hot Streak

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, recently announced revenue guidance for 2022, anticipating another strong period ahead. The company expects revenues of $11.5 million for the first quarter, an increase of 111% over Q1 2021, and $46 million to $48 million in full-year revenues, an increase of 46% to 52% over 2021 unaudited revenue of approximately $31.5 million. SRAX solutions are built to bring clarity and make the digital space more transparent, designed to deliver unbiased data and reveal analytics for companies to manage…

Site Search

Company Search

Category: Stock Spotlight